首页> 外文期刊>Antimicrobial agents and chemotherapy. >Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.
【24h】

Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.

机译:大环内酯类抗生素对铜绿假单胞菌,洋葱伯克霍尔德菌,嗜麦芽窄食单胞菌和从囊性纤维化患者分离的产木素氧化酶的协同作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Azithromycin and clarithromycin were paired with other antibiotics to test synergistic activity against 300 multidrug-resistant pathogens isolated from cystic fibrosis (CF) patients. Clarithromycin-tobramycin was most active against Pseudomonas aeruginosa and inhibited 58% of strains. Azithromycin-trimethoprim-sulfamethoxazole, azithromycin-ceftazidime, and azithromycin-doxycycline or azithromycin-trimethoprim-sulfamethoxazole inhibited 40, 20, and 22% of Stenotrophomonas maltophilia, Burkholderia cepacia complex, and Achromobacter (Alcaligenes) xylosoxidans strains, respectively.
机译:将阿奇霉素和克拉霉素与其他抗生素配对以测试针对从囊性纤维化(CF)患者中分离出来的300种多药耐药病原体的协同活性。克拉霉素-妥布霉素对铜绿假单胞菌最有效,可抑制58%的菌株。阿奇霉素-甲氧苄啶-磺胺甲恶唑,阿奇霉素-头孢他啶和阿奇霉素-强力霉素或阿奇霉素-甲氧苄啶-磺胺甲恶唑分别抑制嗜麦芽窄食单胞菌,嗜酸伯克霍尔德氏菌复合体和无色杆菌的40%,20%和22%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号